Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Absence of hematopoietic tissue factor pathway inhibitor mitigates bleeding in mice with hemophilia.

Maroney SA, Cooley BC, Ferrel JP, Bonesho CE, Nielsen LV, Johansen PB, Hermit MB, Petersen LC, Mast AE.

Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3927-31. doi: 10.1073/pnas.1119858109.

2.

New insights into the biology of tissue factor pathway inhibitor.

Maroney SA, Mast AE.

J Thromb Haemost. 2015 Jun;13 Suppl 1:S200-7. doi: 10.1111/jth.12897. Review.

3.

Expression of tissue factor pathway inhibitor by endothelial cells and platelets.

Maroney SA, Mast AE.

Transfus Apher Sci. 2008 Feb;38(1):9-14. doi: 10.1016/j.transci.2007.12.001. Review.

4.

Cellular expression and biological activities of alternatively spliced forms of tissue factor pathway inhibitor.

Maroney SA, Hansen KG, Mast AE.

Curr Opin Hematol. 2013 Sep;20(5):403-9. doi: 10.1097/MOH.0b013e3283634412. Review.

5.

Hemostatic properties of a TFPI antibody.

Petersen LC.

Thromb Res. 2012 May;129 Suppl 2:S44-5. doi: 10.1016/j.thromres.2012.02.030. Review.

PMID:
22405586
6.

Tissue factor pathway inhibitor (TFPI)--an update.

Sandset PM.

Haemostasis. 1996 Oct;26 Suppl 4:154-65. Review.

PMID:
8979119
7.

Tissue factor pathway inhibitor gene disruption.

Broze GJ Jr.

Blood Coagul Fibrinolysis. 1998 Mar;9 Suppl 1:S89-92. Review.

PMID:
9819035
8.

Tissue factor pathway inhibitor: then and now.

Ellery PE, Adams MJ.

Semin Thromb Hemost. 2014 Nov;40(8):881-6. doi: 10.1055/s-0034-1395153. Review.

PMID:
25377319
9.

Rethinking events in the haemostatic process: role of factor V and TFPI.

Camire RM.

Haemophilia. 2016 Jul;22 Suppl 5:3-8. doi: 10.1111/hae.13004. Review.

PMID:
27405668
10.

Tissue Factor Pathway Inhibitor: Multiple Anticoagulant Activities for a Single Protein.

Mast AE.

Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):9-14. doi: 10.1161/ATVBAHA.115.305996. Review.

11.

Hemophilia A and hemophilia B: focus on arthropathy and variables affecting bleeding severity and prophylaxis.

Escobar M, Sallah S.

J Thromb Haemost. 2013 Aug;11(8):1449-53. doi: 10.1111/jth.12317. Review.

12.

Recent advances in the development of coagulation factors and procoagulants for the treatment of hemophilia.

Schaub RG.

Biochem Pharmacol. 2011 Jul 15;82(2):91-8. doi: 10.1016/j.bcp.2011.03.015. Review.

PMID:
21453683
13.

Wound healing in hemophilia B mice and low tissue factor mice.

Monroe DM, Mackman N, Hoffman M.

Thromb Res. 2010 Apr;125 Suppl 1:S74-7. doi: 10.1016/j.thromres.2010.01.043. Review.

14.

Alternatively spliced tissue factor pathway inhibitor: functional implications.

Mast AE.

Front Biosci (Schol Ed). 2011 Jun 1;3:1457-62. Review.

Items per page

Supplemental Content

Support Center